РЕМЕДИУМРЕМЕДИУМ1561-59362658-3534Joint-Stock Company Chicot175210.32687/1561-5936-2025-29-1-37-41Original ArticleМедико-социальные аспекты хронической болезни почекБезымянныйАлексей Сергеевичdkd@zdrav.mos.ruМингазоваЭльмира Нурисламовнаelmira_mingazova@mail.ruДирекция по координации деятельности медицинских организаций Департамента здравоохранения города Москвы, Москва, РоссияКазанский государственный медицинский университет, Казань, РоссияНациональный научно-исследовательский институт общественного здоровья имени Н. А. Семашко, г. Москва, Российская Федерация151220251374115102025Copyright © 2025, АО "Шико"2025В современном мире определяются высокие риски поражения почек у стареющего населения, особенно при наличии тяжёлых сопутствующих состояний, таких как сахарный диабет, артериальная гипертензия, сердечно-сосудистые заболевания, а также после проведения сложных хирургических операций. После достижения возраста 40—50 лет наблюдается постепенное снижение скорости клубочковой фильтрации — показателя, отражающего эффективность работы почек. К социальным детерминантам хронической болезни почек относят образ и условия жизни, включая состояние жилищных условий, продовольственную безопасность, психологические факторы, социально-экономический уровень, уровень образования, доступность медицинской помощи. Скрининг, в первую очередь нацеленный на лиц с высоким риском, включая пациентов с гипертонией, сахарным диабетом и людей старше 65 лет, внедряется во всём мире для выявления лиц с хронической болезнью почек.chronic kidney diseasemedical and social factorsrisksdeterminantsold agescreening diagnosticsхроническая болезнь почекмедико-социальные факторырискидетерминантыпожилой возрастскринингдиагностика[Wolf U, Ghadir H, Drewas L, Neef R. Underdiagnosed CKD in geriatric trauma patients and potent prevention of renal impairment from polypharmacy risks through Individual Pharmacotherapy Management (IPM-III). J Clin Med. 2023;12(13):4545. DOI: 10.3390/jcm12134545][Vaidya SR, Aeddula NR. Chronic kidney disease. Treasure Island; 2024.][Oude Engberink A, Tessier G, Kamil I, et al. General practitioners' representation of early-stage CKD is a barrier to adequate management and patient empowerment: a phenomenological study. J Nephrol. 2024;37(2):379—390. DOI: 10.1007/s40620-023-01838-y][Covic A, Säemann M, Filipov J, et al. The importance of early diagnosis and intervention in chronic kidney disease: calls-to-action from nephrologists based mainly in Central/Eastern Europe. Kidney Blood Press. Res. 2024;49(1):218—227. DOI: 10.1159/000538165][Czupryniak L, Mosenzon O, Rychlík I, et al. Barriers to early diagnosis of chronic kidney disease and use of sodium-glucose cotransporter-2 inhibitors for renal protection: a comprehensive review and call to action. Diabetes Obes Metab. 2024;26(10):4165—4177. DOI: 10.1111/dom.15789][Hahn KM, Strutz F. The early diagnosis and treatment of chronic renal insufficiency. Dtsch Arztebl Int. 2024;121(13):428—435. DOI: 10.3238/arztebl.m2024.0072][Stolpe S, Kowall B, Scholz C, et al. High unawareness of chronic kidney disease in Germany. Int J Environ Res Public Health. 2021;18(22):11752. DOI: 10.3390/ijerph182211752][Kim V, Zhakhina G, Gusmanov A, et al. Late diagnosis of CKD and associated survival after initiation of renal replacement therapy in Kazakhstan: analysis of nationwide electronic healthcare registry 2014—2019. Ren Fail. 2024;46(2):2398182. DOI: 10.1080/0886022X.2024.2398182][Matsuoka T, Abe M, Kobayashi H. Iron metabolism and inflammatory mediators in patients with renal dysfunction. Int J Mol Sci. 2024;25(7):3745. DOI: 10.3390/ijms25073745][Koyama AK, Nee R, Yu W, et al. Homelessness and risk of end-stage kidney disease and death in veterans with chronic kidney disease. JAMA Netw Open. 2024;7(9):e2431973. DOI: 10.1001/jamanetworkopen.2024.31973][Ozieh MN, Garacci E, Walker RJ, et al. The cumulative impact of social determinants of health factors on mortality in adults with diabetes and chronic kidney disease. BMC Nephrol. 2021;22(1):76. DOI: 10.1186/s12882-021-02277-2][Quiñones J, Hammad Z. Social determinants of health and chronic kidney disease. Cureus. 2020;12(9):e10266. DOI: 10.7759/cureus.10266][Norris KC, Beech BM. Social determinants of kidney health: focus on poverty. Clin J Am Soc Nephrol. 2021;16(5):809—811. DOI: 10.2215/CJN.12710820][Martino FK, Fanton G, Zanetti F, et al. Stage 5 chronic kidney disease: epidemiological analysis in a NorthEastern district of Italy focusing on access to nephrological care. J Clin Med. 2024;13(4):1144. DOI: 10.3390/jcm13041144][Oliva-Damaso N, Delanaye P, Oliva-Damaso E, et al. Risk-based versus GFR threshold criteria for nephrology referral in chronic kidney disease. Clin Kidney J. 2022;15(11):1996—2005. DOI: 10.1093/ckj/sfac104][Mutatiri C, Ratsch A, McGrail M, et al. Primary and specialist care interaction and referral patterns for individuals with chronic kidney disease: a narrative review. BMC Nephrol. 2024;25(1):149. DOI: 10.1186/s12882-024-03585-z][Hsiao PJ, Wang RL, Hu FK, et al. Biomedical evaluation of early chronic kidney disease in the air force: building a predictive model from the Taiwan Military Health Service. Bioengineering (Basel). 2024;11(3):231. DOI: 10.3390/bioengineering11030231][Sun R, Jia J, Wang S, et al. Mediation effect of antithrombin III between chronic renal insufficiency and chronic coronary artery disease in T2DM patients. Endocrine. 2024;84(3):924—933. DOI: 10.1007/s12020-023-03669-04][Zhang Z, Lv L, Guan S, et al. Association between serum methylmalonic acid and chronic kidney disease in adults: a cross-sectional study from NHANES 2013—2014. Front Endocrinol (Lausanne). 2024;15:1434299. DOI: 10.3389/fendo.2024.1434299][Li K, Pirabhahar S, Thomsett M, et al. Use of kidney failure risk equation as a tool to evaluate referrals from primary care to specialist nephrology care. Intern Med J. 2024;54(7):1126—1135. DOI: 10.1111/imj.16377][Chu C. D., McCulloch C. E., Hsu R. K. et al. Utility of the kidney failure risk equation and estimated GFR for estimating time to kidney failure in advanced CKD. Am J Kidney Dis. 2023;82(4):386—394.e1. DOI: 10.1053/j.ajkd.2023.03.014][Bundy JD, Mills KT, Anderson AH, et al. Prediction of end-stage kidney disease using estimated glomerular filtration rate with and without race: a prospective cohort study. Ann Intern Med. 2022;175(3):305—313. DOI: 10.7326/M21-2928][Patel DM, Churilla BM, Thiessen-Philbrook H, et al. Implementation of the kidney failure risk equation in a United States nephrology clinic. Kidney Int Rep. 2023;8(12):2665—2676. DOI: 10.1016/j.ekir.2023.09.001][Yoon Y, Kim YM, Lee S, et al. Association between neck circumference and chronic kidney disease in Korean adults in the 2019—2021 Korea national health and nutrition examination survey. Nutrients. 2023;15(24):5039. DOI: 10.3390/nu15245039][Kim YJ, Hwang SD, Oh TJ, et al. Association between obesity and chronic kidney disease, defined by both glomerular filtration rate and albuminuria, in Korean adults. Metab Syndr Relat Disord. 2017;15(8):416—422. DOI: 10.1089/met.2017.0053][Hewapathiranage S, Medagedara A, Nanayakkara N. A critical evaluation of anthropological, biological and geo-environmental factors on chronic kidney disease of unknown aetiology in affected area against unaffected area. Nephrology Dialysis Transplantation. 2022;37:284—340. DOI: 10.1093/ndt/gfac070.002][Gillespie N, Mohandas R. New eGFR equations: implications for cardiologists and racial inequities. Am Heart J Plus. 2023;27:100269. DOI: 10.1016/j.ahjo.2023.100269]